Skip to main navigation
menu
About
Ionis Innovation
Back to main
Overview
Antisense Technology
Optimizing Antisense
Pipeline
Ion-ARPA Initiative
Our Medicines
Patients & Community
Back to main
Overview
Patient Resources
Community Engagement
Patient Experiences
Investors & media
Back to main
Overview
Newsroom
Back to main
Investors & Media
Press Releases
Company Statements
InBriefs
Media Center
Events
Stock Information
Back to main
Investors & Media
Stock Quote & Chart
Analyst Coverage
Ownership Profile
Financials
Back to main
Investors & Media
SEC Filings
Annual Reports
Governance
Back to main
Investors & Media
Governance Documents
Committee Composition
RSU Holdings Guidelines
Investor Resources
Back to main
Investors & Media
Investor FAQs
Contact Us
Careers
Back to main
Overview
Working at Ionis
Employee Spotlight
Intern Program
Post Doctoral Program
Follow Us
twitter-grey
About
Ionis Innovation
Antisense Technology
Pipeline
IonnovatIONS Podcast
Ion-ARPA Initiative
Grants & Sponsorships
Our Medicines
Patients & Community
Overview
Patient Resources
Community Engagement
Patient Experiences
Investors & media
Overview
Newsroom
Press Releases
Company Statements
InBriefs
Media Center
Stock Information
Stock Quote & Chart
Analyst Coverage
Ownership Profile
Financials
SEC Filings
Annual Reports
Governance
Governance Documents
Committee Composition
Investor Resources
Investor FAQs
Settlement Information
Contact Us
Events
Events
Careers
Overview
Working at Ionis
Employee Spotlight
Volunteerism & Philanthropy
Investments in You
Intern Program
Post Doctoral Program
Follow Us
twitter-grey
Investors & Media
Overview
Newsroom
Events
Stock Information
Financials
Governance
Investor Resources
Investor Email alerts
Investor contact
760-603-2331
Email »
Media contact
760-603-4679
Email »
Event details
View all events »
Stifel 2023 Virtual CNS Days
Mar 29, 2023 at 10:00 AM EDT
Listen to webcast